Context Therapeutics Advances Cancer Drug Pipeline Toward Data Readouts
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) expects interim clinical data from two experimental cancer therapies later this year as the biotechnology company advances multiple bispecific antibody programs targeting …
Context Therapeutics Advances Cancer Drug Pipeline Toward Data Readouts Read More